BREAKING: FDA Chief Marty Makary RESIGNS Hours Before Senate Testimony

Liberty Check

• FDA Commissioner Marty Makary abruptly resigned just one day before scheduled Senate testimony — raising serious questions about timing and transparency
• Kyle Diamantas named Acting Commissioner as the White House scrambles to fill leadership vacuum at critical federal health agency
• The sudden departure adds to mounting concerns about accountability and oversight in federal health bureaucracy

The White House dropped a bombshell Tuesday, announcing that Food and Drug Administration (FDA) Commissioner Marty Makary has resigned from his position, effective immediately. The timing has eyebrows raised across Washington.

The resignation comes just one day before Makary was scheduled to testify before the Senate Appropriations Committee. The abrupt departure raises serious questions about what lawmakers were prepared to ask — and what answers Makary may have preferred not to give under oath.

Kyle Diamantas has been named Acting Commissioner as the agency scrambles to maintain stability. But the sudden leadership change at one of the nation’s most powerful regulatory bodies has conservatives demanding answers about accountability and transparency.

The FDA wields enormous power over American healthcare, pharmaceuticals, and medical devices. Its decisions affect every American family. That kind of authority demands the highest standards of public accountability — including showing up to answer questions from the people’s elected representatives.

Walking away the day before scheduled Senate testimony looks like avoidance, not leadership. Americans deserve regulators who are willing to defend their decisions in public, not officials who exit stage left when the spotlight gets too bright.

The timing of this resignation is suspicious at best. Federal health agencies have faced mounting scrutiny over transparency, regulatory overreach, and accountability to the American people. This sudden departure does nothing to restore public confidence.

As Acting Commissioner Diamantas steps into the role, the Senate must press forward with its oversight responsibilities. The questions that were going to be asked of Makary don’t disappear just because he did. Taxpayers fund these agencies — and they deserve straight answers.

Americans deserve better.